BAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis

Por Bingham, Clifton O., Winthrop, Kevin L., Yang, Lili, Lee, Chin, Komocsar, Wendy J.
Publicado no Arthritis Res Ther (2015)

A 52-week, open-label study evaluating the safety and efficacy of tabalumab, an anti-B-cell–activating factor monoclonal antibody, for rheumatoid arthritis

Por Greenwald, Maria, Szczepanski, Leszek, Kennedy, Alastair, Veenhuizen, Melissa, Komocsar, Wendy J, Polasek, Emery, Guerrettaz, Kelly, Berclaz, Pierre-Yves, Lee, Chin
Publicado em 2014

Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a...

Por Schiff, Michael, Combe, Bernard, Dörner, Thomas, Kremer, Joel M, Huizinga, Thomas W, Veenhuizen, Melissa, Gill, Anne, Komocsar, Wendy, Berclaz, Pierre-Yves, Ortmann, Robert, Lee, Chin
Publicado no RMD Open (2015)